These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist. Adler M; Lazarus RA; Dennis MS; Wagner G Science; 1991 Jul; 253(5018):445-8. PubMed ID: 1862345 [TBL] [Abstract][Full Text] [Related]
24. Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. Aumailley M; Gurrath M; Müller G; Calvete J; Timpl R; Kessler H FEBS Lett; 1991 Oct; 291(1):50-4. PubMed ID: 1718779 [TBL] [Abstract][Full Text] [Related]
25. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length. Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688 [TBL] [Abstract][Full Text] [Related]
26. Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor. Zablocki JA; Miyano M; Garland RB; Pireh D; Schretzman L; Rao SN; Lindmark RJ; Panzer-Knodle SG; Nicholson NS; Taite BB J Med Chem; 1993 Jun; 36(13):1811-9. PubMed ID: 8515420 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic. Hirschmann R; Yao W; Cascieri MA; Strader CD; Maechler L; Cichy-Knight MA; Hynes J; van Rijn RD; Sprengeler PA; Smith AB J Med Chem; 1996 Jun; 39(13):2441-8. PubMed ID: 8691440 [TBL] [Abstract][Full Text] [Related]
28. Structural and functional aspects of RGD-containing protein antagonists of glycoprotein IIb-IIIa. Lazarus RA; McDowell RS Curr Opin Biotechnol; 1993 Aug; 4(4):438-45. PubMed ID: 7763974 [TBL] [Abstract][Full Text] [Related]
29. Conformations of cyclic pentapeptide endothelin receptor antagonists. Bean JW; Peishoff CE; Kopple KD Int J Pept Protein Res; 1994 Sep; 44(3):223-32. PubMed ID: 7822098 [TBL] [Abstract][Full Text] [Related]
30. Structural studies of a neuropeptide precursor protein with an RGD proteolytic site. Zachariah C; Cameron A; Lindberg I; Kao KJ; Beinfeld MC; Edison AS Biochemistry; 2001 Jul; 40(30):8790-9. PubMed ID: 11467939 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and pharmacological characterization of fluorescein-derived endothelin antagonists Bq-123 and Bq-788. Brosseau JP; Neugebauer WA; Gobeil F; D'Orléans-Juste P Adv Exp Med Biol; 2009; 611():443-4. PubMed ID: 19400258 [No Abstract] [Full Text] [Related]
32. Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonist. Duggan ME; Naylor-Olsen AM; Perkins JJ; Anderson PS; Chang CT; Cook JJ; Gould RJ; Ihle NC; Hartman GD; Lynch JJ J Med Chem; 1995 Aug; 38(17):3332-41. PubMed ID: 7650686 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological activity and conformational study of a somatostatin hexapeptide analogue containing a reduced peptide bond. Delaet NG; Verheyden P; Velkeniers B; Hooghe-Peters EL; Bruns C; Tourwé D; Van Binst G Pept Res; 1993; 6(1):24-30. PubMed ID: 8094990 [TBL] [Abstract][Full Text] [Related]
34. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay. Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of small cyclic peptides via reverse turn induced ring closing metathesis of tripeptides. Prabhakaran EN; Rao IN; Boruah A; Iqbal J J Org Chem; 2002 Nov; 67(23):8247-50. PubMed ID: 12423162 [TBL] [Abstract][Full Text] [Related]
37. Glycoprotein IIb peptide 656-667 mimics the fibrinogen gamma chain 402-411 binding site on platelet integrin GPIIb/IIIa. Calvete JJ; Rivas G; Schäfer W; McLane MA; Niewiarowski S FEBS Lett; 1993 Nov; 335(1):132-5. PubMed ID: 8243658 [TBL] [Abstract][Full Text] [Related]
38. Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs. Vickers S; Duncan CA; Yuan AS; Vyas KP Drug Metab Dispos; 1994; 22(4):631-6. PubMed ID: 7956740 [TBL] [Abstract][Full Text] [Related]
39. Conformational study of cyclo(1,5)-Ac-Pen-Arg-Gly-Asp-Cys-NH2 in water by NMR and molecular dynamics. Siahaan TJ; Chakrabarti S; Vander Velde D Biochem Biophys Res Commun; 1992 Sep; 187(2):1042-7. PubMed ID: 1530602 [TBL] [Abstract][Full Text] [Related]
40. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets. Mohri H; Ohkubo T Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]